Skip to main content

Table 1 Baseline patients characteristics

From: Endomyocardial biopsy via the femoral access - still safe and valuable diagnostic tool

Baseline characteristics All patients (n = 73) HTx recipients (n = 32) Other patients (n = 41)
Age (years) 47.6 ± 12.1 48.91 ± 11.24 40.02 ± 14.53
Sex
 Females 16 9 7
 Males 57 23 32
 BMI (kg/m2) 24.37 ± 4.11 24.31 ± 3.99 24.05 ± 5.43
NYHA Class
 I, II, 35 31 4
 III, IV 39 1 38
 Coronary artery disease 3 3 0
 Myocardial infarction 0 0 0
 Hypertension 11 11 0
 Diabetes mellitus 9 9 0
 Prior pacemaker implantation 2 2 0
 Prior cardioverter-defibrilator implantation 0 0 0
 Prior cardiac resynchronisation therapy device implantation 0 0 0
 Prior rheumatic disease 1 1 0
 Renal failure 14 9 5
 GFR (ml/min/m2) 71.66 ± 23.48 53.2 ± 23.16 72.83 ± 12.17
Blood pressure (mmHg)
 Systolic 127.58 ± 15.29 129.89 ± 33.3 99.00 ± 12.04
 Diastolic 81.38 ± 11.23 82.95 ± 9.54 81.38 ± 11.23
Electrocardiogram
 Sinus rhytm 70 30 42
 Atrioventricular block 0 0 0
 Left Bundle Branch Block 4 2 2
 Right Bundle Branch Block 6 6 0
 Heart rate on admission (min−1) 95.26 ± 13.48 95.98 ± 13.37 84.60 ± 12.18
 PQ-interval (s) 0.147 ± 0.043 0.160 ± 0.06 0.14 ± 0.06
 QRS-width (s) 0.119 ± 0.022 0.120 ± 0.06 0.18 ± 0.018
 QT-interval (s) 0.36 ± 0.32 0.38 ± 0.14 0.36 ± 0.50
 ST-segment alterations 5 2 3
 Negative T-wave 5 2 3
Cardiac Biomarkers
 Creatine kinase (U/L) 85.78 ± 82.17 38.26 ± 75.68 187.00 ± 192.85
 Creatine kinase- MB (U/L) 21.44 ± 8.64 21.27 ± 8.86 16.2 ± 15.81
 Troponin I (ng/mL) 0.37 ± 1.67 0.23 ± 0.97 4.51 ± 2.75
 Brain natriuretic peptide (pg/mL) 312.08 ± 365.13 261.13 ± 284.35 948.02 ± 641.85
Laboratory results on admission
 C-reactive protein (mg/L) 32.29 ± 8.72 12.21 ± 34.35 47.18 ± 62.20
 Hemoglobin concentatration (mmol/L) 7.8 ± 1.2 7.61 ± 1.04 10.35 ± 0.67
 White blood cell count (1 × 109/L) 6.47 ± 3.44 6.23 ± 3.19 10.23 ± 5.41
 Platelets count (1 × 109/L) 107.78 ± 57.27 205.13 ± 56.97 215.83 ± 55.42
Echocardiography
 Ejection fraction (%) 61.24 ± 14.65 64.32 ± 8.92 17.67 ± 5.16
 Left ventricle end diastolic diameter (mm) 45.92 ± 14.65 44.41 ± 4.58 68.33 ± 10.04
 Interventricular septum (mm) 11.9 ± 2.14 12.00 ± 2.07 9.91 ± 2.20
 Posterior wall (mm) 11.38 ± 2.73 11.42 ± 2.73 10.75 ± 2.98
 Right ventricle end diastolic diameter (mm) 28.19 ± 4.23 27.98 ± 4.13 32.00 ± 4.20
 Right ventricular systolic pressure (mmHg) 32.39 ± 8.72 32.27 ± 9.00 33.25 ± 4.71
Pericardial effusion
 < 4 mm 6 4 2
 > 4 mm 0 0 0
Tricuspid valve dysfunction
 Mild 5 5 2
 Moderate 3 1 6
 Severe 0 0 2
Cardiac catheterization
Right atrial pressure (mmHg)
 Systolic 14.00 ± 7.18 12.00 ± 6.00 16.00 ± 9.00
 Diastolic 8.00 ± 5.30 6.00 ± 3.50 10.00 ± 7.00
 Mean 11 ± 6.14 8.00 ± 2.70 14.00 ± 8.00
Right ventricular pressure (mmHg)
 Systolic 39.2 ± 17.73 27.00 ± 6.00 51.00 ± 18.4
 Diastolic 7.33 ± 8.55 6.00 ± 4.00 8.00 ± 9.00
 End diastolic 10 ± 6.83 4.00 ± 5.50 15.00 ± 5.00
Pulmonary Artery Pressure (mmHg)
 Systolic 31.00 ± 11.64 24.00 ± 7.00 39.00 ± 11.00
 Diastolic 16.33 ± 9.91 12.00 ± 5.00 20.00 ± 13.00
 Mean 19.30 ± 13.70 15 ± 7.00 30.00 ± 16.50
  1. Continuous variables are presented as mean ± SD. Categorical variables are presented as absolute values (n=). NYHA New York Heart Association